Comparing the performance of quantiferon-TB gold and mantoux test in detecting latent tuberculosis infection among iranian health care workers

International Journal of Occupational Medicine and Environmental Health

Volumn 24, Issue 4, 2011, Pages 359-366

  Talebi Taher, Mahshid ^a   Javad Moosavi, Seied Ali ^a   Entezari, Amir Hossein ^a   Shekarabi, Mehdi ^a   Parhizkar, Baran ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Health care workers; Latent tuberculosis infection; Mantoux test; QuantiFERON TB Gold

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IRAN; ISOLATION AND PURIFICATION; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; PREDICTIVE VALUE; STANDARD; TUBERCULIN TEST;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PERSONNEL; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; IRAN; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; PREDICTIVE VALUE OF TESTS; TUBERCULIN TEST; YOUNG ADULT;

EID: 84858765914     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: 10.2478/s13382-011-0046-7     Document Type: Article

References (35)

1. Cook S, Maw KL, Munsiff SS, Fujiwara PI, Frieden TR. Prev-alence of tuberculin skin test positivity and conversions among healthcare workers in New York City during 1994 to 2001. Infect Control Hosp Epidemiol 2003;24(11):807-13. (Pubitemid 37516809)
2. Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low-and middle-income countries: a sys-tematic review. PLoS Med 2006;3(12):e494.
3. Nikokar I, Dadgran A, Mafozei L. A comparison of two-step Tuberculin Skin Test between Health-Care Workers and Non-hospital Employees. Iran J Med Sci 2010;35(3):201-4.
4. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367(9514):938-40.
5. Singh D, Sutton C, Woodcock A. Tuberculin test measure-ment: variability due to the time of reading. Chest 2002;122(4): 1299-301. (Pubitemid 35339544)
6. Lee E, Holzman RS. Evolution and current use of the tubercu-lin test. Clin Infect Dis 2002;34(3):365-70. (Pubitemid 34062238)
7. Streeton JA, Desem N, Jones SL. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 1998 ;2(6):443-50. (Pubitemid 28326307)
8. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Me-tchock B, Vernon A. Guidelines for using the QuantiF-ERON-TB Gold test for detecting Mycobacterium tu-berculosis infection, United States. MMWR Recomm Rep 2005;54(RR-15): 49-55.
9. Mardani M, Tabarsi P, Mohammadtaheri Z, Chitsaz E, Farokhzad B, Hadavand F, et al. Performance of QuantiFER-ON-TB Gold test compared to tuberculin skin test in detect-ing latent tuberculosis infection in HIV-positive individuals in Iran. Ann Thorac Med 2010;5(1):43-6.
10. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Miglio-ri GB, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011;37(1):100-11.
11. Fietta A, Meloni F, Cascina A, Morosini M, Marena C, Troupioti P, et al. Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection. Am J Infect Con-trol 2003;31(6):347-53. (Pubitemid 37222811)
12. Britton WJ, Gilbert GL, Wheatley J, Leslie D, Rothel JS, Jones SL, et al. Sensitivity of human gamma interferon assay and tuberculin skin testing for detecting infection with Myco-bacterium tuberculosis in patients with culture positive tubercu-losis. Tuberculosis (Edinb) 2005;85(3):137-45. (Pubitemid 40585803)
13. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lan-cet 2000;356(9235):1099-104.
14. Ozdemir D, Annakkaya AN, Tarhan G, Sencan I, Cesur S, Balbay O, et al. Comparison of the tuberculin skin test and the quantiferon test for latent Mycobacterium tuberculo-sis infections in health care workers in Turkey. Jpn J Infect Dis 2007;60(2-3):102-5. (Pubitemid 47009525)
15. Schablon A, Beckmann G, Harling M, Diel R, Nienhaus A. Prevalence of latent tuberculosis infection among health care workers in a hospital for pulmonary diseases. J Occup Med Toxicol 2009;4:1.
16. Soborg B, Andersen AB, Larsen HK, Weldingh K, Ander-sen P, Kofoed K, et al. Detecting a low prevalence of latent tu-berculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis 2007;39(6-7):554-9. (Pubitemid 47009164)
17. Casas I, Latorre I, Esteve M, Ruiz-Manzano J, Rodriguez D, Prat C, et al. Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers. PLoS One 2009;4(8):e6686.
18. Demkow U, Broniarek-Samson B, Filewska M, Lewandows-ka K, Maciejewski J, Zycinska K, et al. Prevalence of latent tuberculosis infection in health care workers in Poland assessed by interferon-gamma whole blood and tuberculin skin tests. J Physiol Pharmacol 2008;59 Suppl 6:209-17.
19. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare work-ers. Infect Control Hosp Epidemiol 2006;27(5):442-8. (Pubitemid 43835524)
20. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendi-ratta DK, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005;293(22):2746-55. (Pubitemid 40973379)
21. Rafiza S, Rampal KG, Tahir A. Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia. BMC Infect Dis 2011;11:19.
22. Schablon A, Harling M, Diel R, Nienhaus A. Risk of latent TB infection in individuals employed in the healthcare sec-tor in Germany: a multicentre prevalence study. BMC Infect Dis 2010;10:107.
23. Teixeira EG, Menzies D, Comstock GW, Cunha AJ, Krit-ski AL, Soares LC, et al. Latent tuberculosis infection among undergraduate medical students in Rio de Janeiro State, Brazil. Int J Tuberc Lung Dis 2005;9(8):841-7. (Pubitemid 41139640)
24. Mirtskhulava V, Kempker R, Shields KL, Leonard MK, Tsertsvadze T, del Rio C, et al. Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia. Int J Tuberc Lung Dis 2008;12(5):513-9. (Pubitemid 351703058)
25. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tu-berc Lung Dis 2007 Jun;11(6):593-605. (Pubitemid 46868618)
26. Pottumarthy S, Morris AJ, Harrison AC, Wells VC. Evaluation of the tuberculin gamma interferon assay: po-tential to replace the Mantoux skin test. J Clin Microbi-ol 1999;37(10):3229-32. (Pubitemid 29455210)
27. Nienhaus A, Schablon A, Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection -analysis of dis-cordant results, when compared to the tuberculin skin test. PLoS One 2008;3(7):e2665.
28. Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Myco-bacterium tuberculosis infection in healthcare staff and associ-ation between positive test results and known risk factors for in-fection. Infect Control Hosp Epidemiol 2009;30(3):215-21.
29. Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F. Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis 2005;40(2):211-7. (Pubitemid 40110663)
30. Herrmann JL, Simonney N, Bergeron A, Ducreux-Adol-phe N, Porcher R, Rouveau M, et al. IFNgamma and antibody responses among French nurses during a tuber-culosis contact tracing investigation. Pathol Biol (Par-is) 2009;57(3):e49-53.
31. Nienhaus A, Schablon A, Bacle CL, Siano B, Diel R. Evalu-ation of the interferon-gamma release assay in healthcare work-ers. Int Arch Occup Environ Health 2008;81(3):295-300. (Pubitemid 350182815)
32. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008;177(10):1164-70. (Pubitemid 351717577)
33. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jef-fries DJ, Lugos MD, et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 2007;4(6):e192.
34. Wrighton-Smith P, Zellweger JP. Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 2006;28(1):45-50. (Pubitemid 44914259)
35. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of un-certainty and recommendations for research. Ann Intern Med 2007;146(5):340-54. (Pubitemid 351650594)